When was S2 Genomics founded?

S2 Genomics was founded in 2016 and raised its 1st funding round 2 years after it was founded.

Where is S2 Genomics located?

S2 Genomics is headquartered in Livermore, United States.

Who is the current CEO of S2 Genomics?

Stevan Jovanovich of S2 Genomics. They have also founded 1 company.

How many employees does S2 Genomics have?

As of Jul 01, 2024, the latest employee count at S2 Genomics is 21.

Is S2 Genomics a funded company?

S2 Genomics is a funded company, having raised a total of $16M across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jun 13, 2018.

When was the latest funding round of S2 Genomics?

S2 Genomics' latest funding was a $***** Series A round on Jan 23, 2024, with participation from 2 investors. Its primary sector is Genomics. In United States, the Genomics sector has seen $455M in funding in 2026 to date.

Where does S2 Genomics rank among its competitors?

S2 Genomics ranks 5th amongst 124 active competitors, of which 43 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Nanopore, which secured $64.2M in Aug, 2024.

Who are the top competitors of S2 Genomics?

S2 Genomics' top competitors include Nanopore, PacBio and Complete Genomics. Among them, Nanopore secured the most recent funding round in August, 2024.

S2 Genomics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of automated sample preparation systems for genomics. The company is developing single-cell sample preparations solutions for NGS. Their systems are used for processing tissues and liquid samples into genomic samples. The company is also developing a spatial sequencing technology that will capture the spatial location like 3-dimensional coordinates, of single cells in tissue for NGS readout.

Website: s2genomics.com
Email ID: *****@s2genomics.com
Phone Number: +1 **********

Key Metrics

Founded Year

2016

Location

Livermore, United States

Stage

Acquired

Total Funding

$16M in 3 rounds

Latest Funding Round

Series A, Jan 23, 2024, $*****

Investors

Broadoak Capital Partners & 6 more

Ranked

5^th among 124 active competitors

Employee Count

21 as on Jul 01, 2024

Similar Companies

Nanopore & 106 more

Exit Details

Acquired

View S2 Genomics' full profile

S2 Genomics got acquired on Sep 17, 2025.

Click here to take a look at S2 Genomics's acquisition in detail

S2 Genomics has raised a total funding of $16M over 3 rounds. Its first funding round was on Jun 13, 2018. Its latest funding round was a Series A round on Jan 23, 2024 for $*****. 2 investors participated in its latest round. S2 Genomics has 7 institutional investors.

Here is the list of recent funding rounds of S2 Genomics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 23, 2024	8744081	Series A	4119751	9651670	4825866	7496505
May 20, 2021	7623725	Conventional Debt	6582477	6140096	4944154	7032112
Jun 13, 2018	1281940	Grant (prize money)	4652419	3711259	7878485	HHS

Access funding benchmarks and valuations. Sign up today!

View details of S2 Genomics's funding rounds and investors

The founders of S2 Genomics is Stevan Jovanovich. Stevan Jovanovich is the CEO of S2 Genomics.

Here are the details of S2 Genomics' key team members:

Stevan Jovanovich: Founder & CEO of S2 Genomics.
Contact Info: 1 email address

View details of S2 Genomics's Founder profiles and Board Members

S2 Genomics' employee count trend

S2 Genomics has 21 employees as of Jul 24. Here is S2 Genomics's employee count trend over the years:

Uncover S2 Genomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of S2 Genomics include Nanopore, PacBio and Complete Genomics. Here is the list of Top 10 competitors of S2 Genomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nanopore 2005, Oxford (United Kingdom), Public	Developer of nanopore-based electronic systems for the analysis of single molecules	$1.26B	IP Group, Redmile Group & 91 others	75/100
2nd	PacBio 2004, Menlo Park (United States), Public	Developer of instrument systems and software for real-time sequencing of single-molecules	$410M	Deerfield, Kleiner Perkins & 24 others	66/100
3rd	Complete Genomics 2006, San Jose (United States), Acquired	Developer of DNA sequencing platform for human genome sequencing and analysis	$125M	Enterprise Partners Venture Capital, Orbimed ... & 8 others	65/100
4th	Ultima Genomics 2016, Newark (United States), Series D	Developer of high-throughput NGS instrument for research	$600M	Khosla Ventures, General Atlantic & 8 others	62/100
5th	S2 Genomics 2016, Livermore (United States), Acquired	Developer of automated sample preparation systems for genomics	$16M	Tri-Valley Ventures, R42 Group & 5 others	60/100
6th	Singular Genomics 2016, San Diego (United States), Acquired	Provider of next-generation gene sequencing and multi-omics technologies	-	F-Prime Capital, Domain Associates & 5 others	60/100
7th	Bioskryb 2018, Durham (United States), Seed	Developer of a genome sequencing and amplification system	$11.5M	Anzu Partners, Wilson Sonsini Goodrich & Rosati	59/100
8th	Omniome 2013, San Diego (United States), Acquired	Provider of genome sequencing platform	$160M	DCVC, Decheng Capital & 12 others	59/100
9th	ReadCoor 2016, Cambridge (United States), Acquired	Innovating single-cell, spatial, and in situ biology tools for researchers	$55.6M	Decheng Capital, Pavilion Capital Partners ... & 6 others	55/100
10th	Bionano 2002, San Diego (United States), Public	Provider of genome analysis solutions to researchers and clinicians	$124M	Battelle Ventures, Domain Associates & 17 others	55/100